The shift from traditional to modern lead discovery has transformed drug development, offering powerful tools and methodologies to accelerate the identification and optimization of drug candidates.
The introduction of computational methods into drug discovery marked a profound shift in the pharmaceutical and biotech industries.
Nanocarriers have demonstrated high effectiveness in delivering drugs and genes to the brain due to their unique properties.
The saga of antimicrobial peptides unfolds as a testament to scientific ingenuity and therapeutic resilience.
Researchers are utilizing adenine analogs to create potent inhibitors and agonists, targeting vital cellular pathways from cancer to infectious diseases.
Scientists are striving to understand bioavailability complexities to ensure the equivalence of drug formulations from different manufacturers, crucial for clinical effectiveness.
In the third part of the Biopharm and PK PharmaFEATURES Primer, we take a deeper dive in mathematical modeling to better estimate drug dosing and generate better predictions of drug efficacy vs time of medications.
Bioavailability, fundamental in pharmacology, explores intricate drug absorption and distribution in the body.
Plasma drug concentrations monitoring allows medication dose adjustment for individualized and optimized drug therapies.
A drug’s physicochemical properties play a crucial role in their effectiveness and safety.
QSAR promises to improve serotonin studies.
Understanding drug toxicity mechanisms is vital for patient safety and treatment efficacy.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings